Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of ciprofol + remifentanil for gastroscopy in elderly patients
ChiCTR2600117344Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Jan 2026
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol in gastrointestinal conditions (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: 50% Effective Dose of Ciprofol. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
ciprofol
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2600117344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117344.